PGP and idiopathic pulmonary fibrosis: Veerman et al. (2022) explain the interaction between nintedatib, a multi-target tyrosin kinase inhibitor used as first-line monotherapy for idiopathic pulmonary fibrosis (IPF), and green tea with P-gp induction as the most probable mechanism [106].